Cardinal Health (CAH) Sees FY17 EPS at Bottom of Previous Guidance Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Cardinal Health (CAH) PT Lowered to $82 at Barclays
April 19, 2017 8:55 AM EDTBarclays lowered its price target on Cardinal Health (NYSE: CAH) to $82.00 (from $88.00) while maintaining a Overweight rating.
... MoreCardinal Health (CAH) to Acquire Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency Businesses from Medtronic (MDT) for $6.1B
April 18, 2017 6:56 AM EDTCardinal Health (NYSE: CAH) today announced that it has entered into a definitive agreement to acquire Medtronic's (NYSE: MDT) Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash. The purchase price does not include cash tax benefits of at least $100 million. The acquisition is expected to be financed with a combination of $4.5 billion in new senior unsecured notes and existing cash. The transaction is expected to close in the first quarter of Cardinal Health's fiscal year 2018, subject to customary closing conditions, including regulatory clearances.
The Patient... More
